Table 1.
Socio-demographic and clinical characteristics of HIV exposed infants and their mothers who had a follow up at Gondar University Referral Hospital
| Variables | Frequency | Percent |
|---|---|---|
|
Age at enrolment |
|
|
| ≤ 6 weeks |
353 |
69.4 |
| > 6 weeks |
156 |
30.6 |
|
Sex |
|
|
| Male |
263 |
51.7 |
| Female |
246 |
48.3 |
|
Residence |
|
|
| Urban |
424 |
83.3 |
| Rural |
85 |
16.7 |
|
Place of Birth |
|
|
| Hospital |
403 |
79.2 |
| Health center |
57 |
11.2 |
| Home |
49 |
9.6 |
|
Maternal status |
|
|
| Alive |
498 |
97.8 |
| Dead |
11 |
2.2 |
|
Maternal enrolment to ART care (n = 453) |
|
|
| Enrolled |
368 |
81.2 |
| Not enrolled |
85 |
18.8 |
|
Maternal PMTCT intervention* |
|
|
| None |
92 |
18.1 |
| sdNVP |
85 |
16.7 |
| sdNVP + AZT for 7 days |
10 |
2.0 |
| sdNVP + AZT for 4 weeks |
3 |
.6 |
| Already on ART |
189 |
37.1 |
| sdNVP + AZT for 7 days + 3TC |
130 |
25.5 |
|
Infant ARV prophylaxis at birth (n = 495) |
|
|
| Received |
421 |
85.1 |
| Not Received |
72 |
14.5 |
| Not known |
2 |
0.4 |
|
Infant ARV prophylaxis during follow up (n = 491)* |
|
|
| None |
75 |
15.3 |
| sdNVP |
99 |
20.2 |
| sdNVP + AZT for 7 days |
277 |
56.4 |
| sdNVP + AZT for 4 weeks | 40 | 8.1 |
*AZT, Zidovidine; sdNVP, Single dose Neverapine; 3TC, Lamuvidine.